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Abstract
Mechanisms leading to liver damage in chronic hepatitis C (CHC) are being discussed, but both the immune system and the virus are involved.
The aim of this study was to evaluate intrahepatic viral infection, apoptosis and portal and periportal/interface infiltrate in paediatric and adult
patients to elucidate the pathogenesis of chronic hepatitis C. HCV-infected, activated caspase-3+ and TUNEL+ hepatocytes, as well as total,
CD4+,CD8+, Foxp3+ andCD20+ lymphocytes infiltrating portal and periportal/interface tractswere evaluated in 27 paediatric and 32 adult liver
samples by immunohistochemistry or immunofluorescence. The number of infected hepatocytes was higher in paediatric than in adult samples
(p 0.0078). In children, they correlated with apoptotic hepatocytes (activated caspase-3+r = 0.74, p < 0.0001; TUNEL+r = 0.606, p 0.0017).
Also, infected (p = 0.026) and apoptotic hepatocytes (p = 0.03)were associatedwith the severity of fibrosis. In adults, activated caspase-3+ cell
count was increased in severe hepatitis (p = 0.009). Total, CD4+, CD8+ and Foxp3+ lymphocyte count was higher in adult samples (p < 0.05).
Paediatric CD8+ cells correlatedwith infected (r = 0.495, p 0.04) and TUNEL+ hepatocytes (r = 0.474, p = 0.047), while adult ones correlated
with activated caspase-3+ hepatocytes (r = 0.387, p 0.04). In adults, CD8+ was associated with hepatitis severity (p < 0.0001) and correlated
with inflammatory activity (CD8+ r = 0.639, p 0.0003). HCV, apoptosis and immune response proved to be involved in CHC pathogenesis of
both paediatric and adult patients. However, liver injury in paediatric CHCwould be largely associatedwith a viral cytopathic effectmediated by
apoptosis, while in adults it would be mainly associated with an exacerbated immune response.
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Introduction
Hepatitis related to hepatitis C virus (HCV) is a progressive
disease that may result in chronic active hepatitis, cirrhosis
and hepatocellular carcinoma. It is estimated that about
160 million individuals (i.e. 2.35% of the world’s population)
are chronically infected with HCV [1,2]. The virus represents
a global health problem because there is no available vaccine
and, although there are recently approved direct-acting
antiviral agents (DAA) available as well as more drugs in
the pipeline, response to the current standards of care
therapy (pegylated interferon–a and ribavirin) is limited.
Given these facts, liver failure arising as a consequence of
HCV infection is one of the most common reasons for liver
transplants [1]. Liver disease seems to be milder in children
than in adults; however, the natural history of HCV infection
acquired in infancy and childhood remains poorly character-
ized and the long-term outcome of the disease is still a matter
of debate [3].
The mechanisms leading to liver injury are under constant
revision, but the fact that both immune system-mediated
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reactions and viral cytopathic effects are involved in patho-
genesis is widely accepted [4].
Based on the morphological characteristics of liver biopsies,
it is currently accepted that hepatocyte damage is a result, at
least in part, of apoptosis induction. Both in vitro studies and in
vivo models have demonstrated the ability of HCV to induce
apoptosis [4–7]. Furthermore, some studies including adult
patients indicated that hepatocyte apoptosis plays a significant
role in the pathogenesis of HCV infection, and is clinically
recognized as liver inflammation and fibrosis [6, 8–12].
On the other hand, it is considered that the lack of an
effective immune response during acute HCV infection is the
main cause of chronic hepatitis development [13]. In chronic
hepatitis C (CHC), the CD4+ and CD8+T cell response
appears to be unsuccessful in peripheral blood, but contributes
to the pathogenesis in the liver [14–18]. Normally, CD8+ T
cells are essential for infection control, as they migrate to
infected tissues and mediate viral clearance. However,
HCV-specific CD8+ T cells in CHC patients possess a lesser
capacity to proliferate and produce less IFN-c in response to
viral antigens [19]. Although the reasons for the global failure
of a protective immune response against HCV is not fully
understood, several plausible mechanisms have been pro-
posed: (i) HCV escapes mutations, (ii) primary T cell failure or
T cell exhaustion, (iii) impaired antigen presentation, (iv)
suppression by HCV proteins, (v) impaired T cell maturation,
(vi) suppression by regulatory T (Treg) cells and (vii) a
tolerogenic environment in the liver [13].
Recently, Treg cells have become very important due to
their contribution to the pathogenesis of various diseases,
including hepatic diseases [20]. Accumulating evidence indi-
cates that patients with chronic viral hepatitis display an
increased number of Treg cells in peripheral blood or liver;
however, the increment of Treg cells in CHC and their role in
liver damage development is still a matter of debate [21–26].
Finally, in order to fully understand the pathogenesis of HCV
further investigations are needed. The study of the pathogen-
esis of HCV in patient0s samples instead of animal models, even
taking into account interpatient variability, is crucial to explore
different aspects of infection in its actual context. Moreover,
because most studies are focused on adult cohorts and little is
known about pathogenesis in children, the analysis of paediatric
cases further enriches this study. In addition, it is known that
the HCV immune response is compartmentalized (i.e. fre-
quency and function of various cell types at the intrahepatic
level differ from those at the periphery) [27]. As most studies
are focused on peripheral blood immune cell composition, the
analysis of the inflammatory infiltrate on fixed liver biopsies
that identifies each population in situ provides a more
comprehensive picture of their relationship with injury.
Therefore, our aim was to evaluate intrahepatic infection,
apoptosis and portal and periportal/interface (P-P/I) infiltrate in
liver samples from paediatric and adult patients to further
explore and compare CHC pathogenesis.
Materials and Methods
Patients and samples
Seventy-nine formalin-fixed and paraffin-embedded (FFPE)
liver samples were included in the study. Namely, 27 paediatric
and 32 adult CHC biopsy samples as well as 20 (10 of each age
group) liver samples from healthy donor organ reduction for
liver transplantation were collected from the archives of the
Pathology Division at the Hospital de Ni~nos Ricardo Gutierrez
and Hospital Italiano de Buenos Aires, respectively (Table 1).
Diagnosis was based on the presence of anti-HCV
antibodies in serum samples at or after 18 months of age
and HCV RNA in plasma on at least two separate occasions.
Patients had no other causes of liver disease, autoimmune or
metabolic disorders, hepatocellular carcinoma or co-infection
with HBV and/or HIV. Patients were also treatment na€ıve.
Cases of adults who consumed alcohol (men >80 g/day;
women >60 g/day) were excluded.
Informed consent was obtained from each adult patient and
from parents of paediatric patients. The study protocol
conforms to the ethical guidelines of the 1964 Declaration of
Helsinki and its later amendments, as reflected in a priori
approval by the Ethics in Research Committees of both
institutions.
Tables S1 and S2 show in detail clinical, virological and
histological features of each HCV paediatric and adult patient,
respectively.
Histological analysis
Histological sections were blindly evaluated by two independent
pathologists. Inflammatory activity and fibrosis were assessed
using the modified Knodell scoring system (Histological Activity
Index, HAI) and METAVIR [28]. According to HAI, each biopsy
specimen was categorized as minimal (≤3), mild (4–6), moderate
(7–12) or severe hepatitis (>12) (Table 1).
As METAVIR is a specially designed system for the analysis
of HCV biopsies that it is more accurate for determining
fibrosis stage and modified Knodell classified inflammatory
activity and hepatitis and also provides a deeper characteriza-
tion of damage localization and severity, we selected each
score to quantify the corresponding parameter. Furthermore,
in routine clinical practice both indexes are considered in this
way, which allowed us to clearly compare our results with
those of other authors and to minimize errors.
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Hepatic detection of HCV
Infected hepatocytes were evidenced by detecting viral NS3
protein by manual immunohistochemistry (IHC). Epitope
retrieval was performed with sodium citrate buffer (0.01 M,
pH 6) in an autoclave for 3 min (20 psi). Endogenous biotin
was blocked with Biotin Blocking System (Avidin/Biotin
Blocking Kit, Vector Laboratories Inc, Burlingame, USA). A
primary mouse antibody to NS3 (1:25, clone MMM33, Abcam,
Cambridge, UK) was used for 1 h at 25°C and staining was
obtained by applying the streptavidin-biotin peroxidase (SBP)
system and substrate-chromogen reagent (Vectastain Elite
ABC and DAB Substrate Kit for Peroxidase, Vector Labora-
tories Inc, Burlingame, USA). Positive staining was not
observed without the NS3 primary antibody or with isotype
control. No labelling was detected when evaluating antibody
specificity on chronic HBV-infected liver samples.
Apoptotic hepatocytes
Activated caspase-3 (casp-3a) labelling was performed using
rabbit polyclonal anti-casp-3a antibody (1:1000, AF835, R&D
systems, Minneapolis, MN, USA) as previously described [29].
Non-alcoholic steatohepatitis liver biopsy samples that were
casp-3a positive were used as positive control. Isotype control
was performed.
DNA fragmentation was visualized using the ApopTag Plus
Fluorescein In Situ Apoptosis Detection Kit (CHEMICON
International, Inc., Billerica, MA, USA) according to the
manufacturer’s instructions. For counterstaining and mounting,
DAPI in PBS-glycerol (DAPI/antifade Solution, CHEMICON
International, Inc.) was used.
Immunohistochemical detection of CD4+, CD8+, Foxp3+ and
CD20+ cells in P-P/I infiltrate
Characterization of the P-P/I infiltrate was performed using
monoclonal antibodies: mouse anti-human CD4 (clone 1F6,
Novocastra, Newcastle, UK), mouse anti-humanCD8 (clone C8/
144B, DakoCytomation, Carpinteria, CA, USA), mouse anti--
Foxp3 (10 mg/mL, clone 236A/E7, Abcam, Cambridge, UK) and
mouse anti-CD20 (clone L26, Novocastra).
After epitope retrieval [sodium citrate buffer (0.01 M, pH 6)
in autoclave during 5 min (20 psi)], sections were incubated
with each primary antibody and stained by applying the
PolyTek HRP anti-Mouse Polymerized Imaging System (ScyTek
Laboratories, Logan, UT, USA) according to the manufac-
turer’s instructions. Tonsil sections were used as positive
controls and isotype controls were performed.
Quantification
Immunostained and total hepatocytes were counted in 20
high-power fields (10009). To characterize P-P/I infiltrates,
immunostained and total P-P/I lymphocytes were counted in
10 portal tracts (4009).
Double immunostaining
The casp-3a/TUNEL: the TUNEL protocol was carried out
according to the manufacturer’s instructions. Tissue pretreat-
ment was performed with Proteinase K (20 mg/mL) for
15 min at 25°C. After the anti-Digoxigenin conjugate step,
sections were incubated in darkness with anti-casp-3a,
followed by a secondary biotinylated antibody (LSAB+Sys-
tem-HRP, DakoCytomation) and streptavidin-AlexaFluor 546
conjugate (Invitrogen Molecular Probes, Eugene, OR, USA).
Finally, samples were counterstained and mounted with DAPI/
antifade solution.
NS3+/TUNEL+: NS3 detection was carried out as described
above and after chromogen addition the TUNEL protocol was
performed.
TABLE 1. Clinical, virological and histological patient fea-
tures
Paediatric patients Adult patients
Age (years)
median (range) 8 (3–14) 51 (38–74)
Male 10 (37.04%) 21 (65.26%)
Duration of infection (years)
Median (range) 4 (1–14) 20 (10–25) a, b
Risk factor for HCV infection
(n) Vertical 44.44% (12) –
Drug abuse – 21.88% (7)
Occupational – 3.12% (1)
Transfusion 40.74% (11) 12.50% (4)
Unknown 14.81% (4) 62.50% (20)
Genotype (%, n) 1 (88.9%, 24) 1 (78.12%, 25)
4 (3.69%, 1) 2 (12.50%, 4)
ND (7.41%, 2) 3 (9.38%, 3)
Viral load (IU/ml)
Median (range) 594 286
(1590–807 739)
560 609
(1410–1.05 9 107)
ALT (IU/l)
Median (range) 43 (11–364) 67 (21–247)
% elevated (n) 70.37% (19) 81.25% (26)
BMI (%)
Overweight 7.40% (2) 37.50% (12)
Obese 18.52% (5) 6.25% (2)
Hepatitis
Minimal (n) 0% (0) 3.12% (1)
Mild (n) 14.81% (4) 15.63% (5)
Moderate (n) 74.08% (20) 53.13% (17)
Severe (n) 11.11% (3) 28.12% (9)
Steatosis
Absent (n) 33.33% (9) 37.50% (12)
Minimal (n) 40.74% (11) 31.25% (10)
Moderate (n) 14.82% (4) 18.75% (6)
Severe (n) 11.11% (3) 12.50% (4)
Fibrosis stage c
F 0–1 (n) 33.33% (9) 31.25% (10)
F 2 (n) 51.85% (14) 31.25% (10)
F 3 (n) 14.82% (4) 31.25% (10)
F 4 (n) 0% (0) 6.25% (2)
Lymphoid follicle
% patients (n) 40.74% (11) 71.87% (23)
Bile duct damage
% patients (n) 77.78% (21) 100% (32)
aData available only from 16 patients.
bDifference in duration of infection between paediatric and adult cases was
statistically significant (p < 0.0001). ND, not determined; ALT, alanine amino-
transferase. Normal ALT levels for paediatric and adult patients were ≤32 and ≤40,
respectively, when test was done at 37°C. BMI, body mass index.
cFibrosis according to METAVIR.
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CD4/Foxp3 and CD8/Foxp3: either CD4 or CD8 immun-
odetection was performed as described above. After signal
amplification, a blocking step was carried out using PBS 1%
bovine serum albumin (30 min at 25°C). Subsequently,
sections were incubated for 1 h at 25°C with anti-Foxp3
antibody. Detection was performed using an anti-mouse
antibody conjugated to FITC (1:100, JacksonImmuno Research,
West Grove, PA, USA) for 18 h at 4°C. Finally, samples were
counterstained and mounted with DAPI/antifade solution.
Isotype controls were also performed.
As detection of NS3, CD4 and CD8 antigens was done using
an SBP system and DAB as substrate, images were converted to
a false red colour with the Image-Pro Plus software version
6.0.0.260 and then merged with fluorescent ones.
Statistical analysis
Statistical analysis was performed using GraphPad InStat
software, version 3.05 (Graphpad, San Diego, CA, USA). The
Mann–Whitney U-test and unpaired t-test were used to
compare sets of data. Pearson’s and Spearman’s correlations
were applied. p < 0.05 values were considered significant.
Results
HCV NS3 detection in liver biopsies
A cytoplasmic, mainly perinuclear, NS3 immunostaining with a
granular pattern of variable intensity was observed (Fig. 1a,b).
In both patient groups, infected hepatocytes were not
uniformly distributed; in some cases they were observed in
intralobular and periportal areas while in others they were
observed only in periportal areas.
Even though the number of infected hepatocytes was
variable, it was significantly increased in paediatric samples
(paediatrics vs. adults median (range): 0.210 (0.004–0.880) vs.
0.105 (0.006–0.449), p 0.0078). In 59.26% of paediatric biop-
sies, the frequency of infected hepatocytes was higher than
20%, whereas in 73.68% of adult ones it was lower than 20%.
No significant correlation with viral load, serum amin-
otransferases or hepatitis severity was found; however, an
association with fibrosis severity (p = 0.03) was observed only
in children (Fig. 1).
Apoptosis in liver tissue sections
All typical signs of apoptosis are the final result of a complex
biochemical cascade of events. Apoptotic signalling mainly
converges in the activation of intracellular caspases, a family of
cystein-dependent aspartate-directed proteases that cleave key
cellular proteins [30]. DNA fragmentation is recognized as an
apoptotic late event, whereas caspase activation measurement
is a suitable marker for detecting early signs of liver apoptosis.
Indeed, it has been reported that activated caspase or
caspase-cleaved substrates are detected in hepatocytes without
late apoptotic features [Bantel et al., 2001]. Given these facts, it
is recommended that apoptosis should be assessed by multiple
methodologies. In consequence, in this study, the activation of
caspase-3 and DNA fragmentation, the final and irreversible
event in the process of apoptosis, were evaluated.
On H&E-stained sections, non-apoptotic cells were identi-
fied by their morphology; however, apoptosis marker detection
allowed for the identification of a significant number of
apoptotic cells without a specific location pattern (Fig. 2 Panel
1 a-c). The inclusive analysis of apoptosis markers showed a
significant correlation between casp-3a+ and TUNEL+ hepato-
cytes (in children r = 0.595, p 0.002; in adults r = 0.558,
p 0.003). The timing of the apoptotic process events was
evidenced through double immunostaining because an excess
of casp-3a+ over TUNEL+ hepatocytes as well as an increased
casp-3a labelling intensity in double-positive hepatocytes was
observed (Fig. 2, Panel 2 a-d). On the other hand, apoptotic
hepatocyte number was significantly higher in CHC samples
compared with control ones (Table 2). Meanwhile, casp-3a
quantification in adult CHC samples was higher than in
paediatric samples (p = 0.0376), and no differences were
observed between control samples from both groups
(Table 2). In paediatric biopsies, HCV+ hepatocytes correlated
with casp-3a+ (r = 0.748, p < 0.0001) and TUNEL+ cells
(r = 0.606, p = 0.0017). Moreover, the number of infected
hepatocytes exceeded that of apoptotic cells in nearly all cases
(100% casp-3a+; 92.59% TUNEL+). Given the observed corre-
lations, double immunostaining was performed in both age
groups. Due to the technical incompatibility of antigen expo-
sure procedures, this approach could only be achieved for NS3
and TUNEL. As shown in Fig. 2 (Panel 3 a-d), induction of
apoptosis was detected in most infected hepatocytes from
paediatric patients. In contrast, no correlation between apop-
tosis and infected hepatocytes was observed in adult samples.
Regarding liver damage, although TUNEL staining showed no
significant association, casp-3a+ hepatocytes count was associ-
ated with fibrosis stage (p 0.026) in paediatric biopsies (Fig. 3a)
and with severe hepatitis (p 0.009) in adult biopsies (Fig. 3d).
Detection of CD4+, CD8+, Foxp3+ and CD20+ cells in P-P/I
infiltrate
CD4+, CD8+, Foxp3+ and CD20+ cells were predominantly
identified in the P-P/I areas (Fig. 4, Panel 1 a-d) while
only scattered lymphocytes were observed in the intralobular
component. The total numbers of P-P/I infiltrating lymphocytes
as well as CD4+, CD8+ and Foxp3+ cells were higher in adult
samples than in paediatric ones [paediatrics vs. adults median
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(range): total P-P/I lymphocytes, 80 (20–580) vs. 373 (198–
906), p < 0.0001; CD4+ cells, 0.031 (0–0.402) vs. 0.138
(0.017–0.503), p 0.022; CD8+ cells, 0.314 (0.040–0.710) vs.
0.485 (0.247–0.642), p 0.0115; Foxp3+ cells, 0.035 (0–0.167)
vs. 0.146 (0.031–0.318), p < 0.0001; CD20+ cells, 0.300
(0.040–0.610) vs. 0.350 (0.055–0.660), p 0.46].
In both age groups CD4/Foxp3, CD8/Foxp3 and CD20/
Foxp3 ratios were calculated for each patient [in children,
median (range): CD4/Foxp3, 2.16 (0–11.57); CD8/Foxp3, 6.25
(1.44–30.18); CD20/Foxp3, 5.08 (1.69–22.57); in adults: CD4/
Foxp3, 0.979 (0.06–3.44); CD8/Foxp3, 3.23 (1.18–10.89);
CD20/Foxp3, 2.39 (1.05–4.59)] to evaluate the proportion of
each cell type when compared with Foxp3+ cells. In the adult
cases, according to CD4/Foxp3 median, it could be assumed
that the CD4+ cell population was mainly composed of
Foxp3+ cells; hence, CD4/Foxp3 double immunostaining was
performed to validate this. Moreover, as in vitro studies
showed CD8+/Foxp3+ cells with regulatory activity [31],
CD8/Foxp3 double immunostaining was also performed. In
P-P/I infiltrates CD4+/Foxp3+ cells were identified in both
groups, with a higher frequency in adult samples (Fig. 4, Panel
2 a-e), while no CD8+/Foxp3+ cells were present at all (Fig. 4,
Panel 2 f-j).
In paediatric patients, CD8+ cells correlated with both
infected (r = 0.495, p = 0.04) and TUNEL+ hepatocytes
(r = 0.474, p 0.047). In adult cases correlations between
CD4+ and CD8+ cells with casp-3a+ hepatocytes (CD4+,
r = 0.624, p 0.0005; CD8+,r = 0.387, p 0.04) were observed.
Regarding histological parameters, none of the lymphocyte
populations studied was associated with liver damage in
children. Only inflammatory activity correlated with total
P-P/I lymphocyte count (r = 0.694, p 0.0002). In adult patients,
no differences were found regarding fibrosis severity; instead,
CD8+ cell count was associated with hepatitis severity
(p < 0.0001)(Fig. 4, Panel 3 g) and also correlated with
inflammatory activity (r = 0.639, p 0.0003).
Discussion
HCV pathogenesis is a very complex phenomenon that still
requires further investigation in order to determine the actual
(a) (b)
(c) (d)
(e) (f)
FIG. 1. Infected hepatocytes in liver
biopsies of CHC patients. NS3
immunostaining (a, b). Infected hepatocytes
showing NS3 cytoplasmic granules. Infected
hepatocytes related to fibrosis (c, d).
Significant fibrosis (F ≥ 2) according to
METAVIR. Infected hepatocytes related to
hepatitis (e, f). L, mild; M, moderate; S,
severehepatitis. Paediatricpatients (c, e) and
adult patients (d, f). The results are depicted
in box plots. Horizontal lines within boxes
indicate medians. Horizontal lines outside
the boxes represent the 5 and 95
percentiles. Mean is indicated as +. Labelled
hepatocytes/total hepatocytes in 20
high-power fields (10009). The Mann-
Whitney U-test and unpaired t-test were
used to compare sets of data.
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role of each of its contributing factors. To date, given the
difficulty in obtaining HCV-infected liver tissue biopsies,
pathogenesis has mainly been studied in in vitro and in vivo
models. Considering that apoptosis and immune response play
an important role in the process and that little is known about
CHC in children, the focus of our analysis was to determine
the potential role and contribution of HCV, apoptosis and
immunity in the pathogenesis of CHC in both adults and
children.
HCV infection is a dynamic process and only limited data
are available about the proportion of infected hepatocytes
during disease. In our series, we reported that the total
amount of HCV infected hepatocytes in most adult cases was
less than 20%, while it was significantly higher in children. It is
accepted that HCV spreading among hepatocytes is controlled
by the intrahepatic immune response during chronic infection.
In our paediatric sample series, we observed an excess of
HCV+ hepatocytes, which implies that the immune system
could not completely achieve virus control. In contrast, in our
adult cases immune response is more represented, as it will be
discussed later. A role for the immune response was also
suggested by other authors who detected 50–70% infected
hepatocytes in liver biopsies from adults with acute hepatitis C
infection while only nearly 20% of infected hepatocytes were
(a) (b)
(a)
(a) (b)
(c) (d)
(e)
(b)
(c) (d)
(c)
FIG. 2. Panel 1: Apoptosis markers in
liver biopsies of CHC patients.
Immunostaining of liver biopsies. (a)
Casp-3a+ cells displaying nuclear staining;
(b) fluorescent nucleus in TUNEL+ cells;
(c) DAPI counterstaining. Panel 2: Double
immunostaining casp-3a/TUNEL. (a) DAPI
counterstaining; (b) Casp-3a+ hepatocytes;
(c) TUNEL+ hepatocyte; (d) merged
images.Panel 3: NS3/TUNEL double
immunostaining. (a) NS3; (b) false red
colour; (c) TUNEL; (d) DAPI
counterstaining; (e) merged images. Note
that the number of infected hepatocytes
exceeded that of apoptotic ones in liver
samples from paediatric patients. Red and
green arrows indicate infected and
apoptotic hepatocytes, respectively.
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detected in chronic infection samples [32,33]. Furthermore, in
our series, infected hepatocytes seemed to contribute to
fibrosis development exclusively in children. In contrast, in our
adult cases, the presence of virus was not correlated with liver
damage, as has been previously proposed by Rodriguez-Inigo
et al. [34]. Finally, no correlation was observed between the
number of infected hepatocytes and viral load in either age
groups, a fact that has also been previously described [32, 35,
36]. A plausible explanation for this observation is that the IHC
approach exclusively detects viral antigens but does not take
into account the actual number of viral particles or their input
into the plasma compartment.
On the other hand, concerning apoptosis, we demonstrated
that this process is a prominent liver feature in CHC patients
because a significantly higher number of apoptotic cells was
identified in CHC biopsies compared with controls, another
fact that is in agreement with previous reports [9, 10, 37–43].
Regarding the role of apoptosis in pathogenesis, many studies
including adult CHC cohorts described conflicting results [10,
37, 39–41, 43, 44]. In our series, when comparing both age
groups, contrasting outcomes were observed. In children,
apoptosis markers were related to infected hepatocytes and
fibrosis severity. Furthermore, apoptosis was detected as an
almost exclusive event of infected hepatocytes by double
immunostaining. The scenario was different in adults: as
previously reported [10, 44, 45], there was a high predom-
inance of apoptotic non-infected hepatocytes along with an
association of apoptosis with hepatitis severity. As apoptosis,
unlike necrosis, occurs without releasing intracellular compo-
nents and does not result in an inflammatory process [46],
apoptosis could be considered the result of the inflammation
rather than its cause.
The liver is a mediator of local and systemic immunity and
hence, an important immune regulation site [47]. It is
considered that HCV persistence is the consequence of
multiple viral factors that interfere with immunity. Depending
on the severity of dysfunction, the HCV-specific immune
response may successfully control viral infection or fail to do
so, while allowing the infiltrating cells to persist in the liver and
contribute to fibrosis [4, 45].
The assessment of the role played by the immune system
in the pathogenesis of CHC in the studied adult cohort
showed that CD8+ cells were increased in severe hepatitis
(a) (b)
(c) (d)
FIG. 3. Apoptosis markers related to
fibrosis (a, b) and to hepatitis (c, d).
Significant fibrosis (F ≥ 2) according to
METAVIR. L, mild; M, moderate; S, severe
hepatitis. Paediatric patients (a, c) and
adult patients (b, d).The results are
depicted in box plots. Horizontal lines
within boxes indicate medians. Horizontal
lines outside the boxes represent the 5
and 95 percentiles. Mean is indicated as +.
Labelled hepatocytes/total hepatocytes in
20 high-power fields (10009). The
Mann-Whitney U-test and unpaired t-test
were used to compare sets of data.
TABLE 2. Quantification of apoptosis markers in control and
CHC liver samples
Casp-3a+hepatocytesa TUNEL+hepatocytesa
Median
(range) p value
Median
(range) p value
Paediatric samples
Controls 0.001 (0–0.005) <0.0001 0.000 (0–0.003) 0.0003
CHC 0.064 (0–0.287) 0.057 (0–0.311)
Adult samples
Controls 0.001 (0–0.009) <0.0001 0.001 (0–0.003) 0.0005
CHC 0.091 (0–0.324) 0.057 (0–0.311)
Paediatric vs.
adult controls
0.1889 0.1358
Paediatric vs.
adult CHC
0.0376 0.35
aNumber of positive hepatocytes/number of total hepatocytes (10009).
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FIG. 4. Panel 1: CD4+, CD8+, Foxp3+ and CD20+immunostaining in liver biopsies of CHC patients. (a) CD4+; (b) CD8+; (c) Foxp3+; (d) CD20+
cells. Panel 2: CD4/Foxp3 and CD8/Foxp3 double immunostaining. (a) CD4+; (b) false red colour; (c) Foxp3+; (d) DAPI counterstaining; (e)
merged images (the insertion shows double positive cell amplification);(f) CD8+; (g) false red colour; (h) Foxp3+; (i) DAPI counterstaining;(j)
merged images (the insertion shows amplification). Panel 3: CD4+, CD8+, Foxp3+, CD20+and total P-P/I lymphocytes related to fibrosis (a-d) and
to hepatits (e-h). CD4+, CD8+, Foxp3+ and CD20+ (a, c, e, g) and total P-P/I lymphocytes (b, d, f, h). Paediatric patients (a, b, e, f) and adult patients
(c, d, g, h). Significant fibrosis (F ≥ 2) according to METAVIR. L, mild; M, moderate; S, severe hepatitis. The results are depicted in box plots.
Horizontal lines within boxes indicate medians. Horizontal lines outside the boxes represent the 5 and 95 percentiles. Mean is indicated as +.
(Labelled P-P/I lymphocytes)/(total P-P/I lymphocytes) in 10 portal tracts (4009). The Mann-Whitney U-test and unpaired t-test were used to
compare sets of data.
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and correlated with inflammatory activity, but there was no
association with fibrosis severity. Besides, CD4+ and CD8+
cell count correlated with apoptotic hepatocytes. As we have
just demonstrated, only a small fraction of hepatocytes were
infected in adult biopsies, but still, many were apoptotic, so it
could be hypothesized that apoptosis activation is not
directly triggered by HCV, but instead could be due to the
antiviral immune response. Therefore, non-infected hepato-
cytes could represent a major contribution to the overall
liver injury. In fact, it has been reported that HCV-specific
CD8+ cells represent only a fraction of the whole intrahe-
patic CD8+ cell population [18]. In this sense, our results
support the ‘Bystander killing’ theory [45, 48, 49], which
suggests that HCV-specific cytotoxic cells eliminate infected
hepatocytes by apoptosis induction and the release of soluble
effectors. Although these soluble effectors aid in the control
of the infection, they also attract non HCV-specific lympho-
cytes, which in turn affect non-infected hepatocytes. In
contrast, in the paediatric cohort, the total P-P/I lymphocyte
numbers were lower, and this may reflect a lighter immune
impact on liver damage. Nevertheless, the observed rela-
tionship among infected hepatocytes, CD8+ cells and apop-
tosis may mirror the classic immune response to viral
infection in which cytotoxic lymphocytes attempt to elimi-
nate infected cells.
With regards to Foxp3+ cells, we demonstrated by simple
and double immunostaining approaches that Foxp3+ cells
constitute a large lymphocyte fraction in CHC biopsies, which
are mainly located in areas where CD8+ cells are predominant.
This observation is also in accordance with previous reports
[24, 50–52]. Moreover, although CD8+/Foxp3+ cells have been
described in CHC biopsies [31, 53],they were under-repre-
sented in our studied series, as in other reports [51,52]. On
the other hand, in our series Foxp3+ cells did not have a clear
impact on fibrosis in either of the studied cohorts because the
proportion of Foxp3+ cells remained similar in both mild and
severe fibrosis, which is in agreement with other authors [26,
51, 52]. It is well known that Treg cells participate in a delicate
intrahepatic balance that results in the attenuation of protec-
tive immunity and immune-mediated damage [50]; however,
concerning their role in CHC liver injury, several controver-
sies exist, particularly related to fibrosis [50–52, 54, 55].
Nevertheless, it should be considered that the expression of
Foxp3 is not equivalent to differentiation of T cells as
regulatory T cells, because up-regulated Foxp3-expression
has also been observed during T-cell activation [56]. The Treg
population in HCV-infected livers is heterogeneous, and both
phenotypical as well as functional features must be considered
in future studies to finally characterize their role in the
pathogenesis [26, 50–52, 57].
HCV, apoptosis and the immune response are all involved in
CHC pathogenesis in both age groups, although certain
differences regarding the weight of each component in the
final scenario were observed between children and adults.
Based on these results, we propose a model of how HCV
pathogenesis could be developed in each age group (Fig. S1). In
paediatric patients, it would be largely HCV that participates in
liver damage. HCV would not have a direct effect on
histological parameters, but instead it would participate
through apoptosis induction, which in turn contributes to
fibrosis development. In contrast, in adult patients, the
prevalence of apoptotic non-infected hepatocytes, related to
hepatitis severity, may indicate that apoptosis could be mainly a
consequence of the immune response to HCV. It could be
hypothesized that the lower impact of the immune response in
children may be related to the high proportion of vertically
infected cases included. As immune system maturation would
be concomitant with HCV infection, this could result in a
tolerogenic environment and consequently the observed
damage could largely mirror a viral effect. In an opposite
manner, it could be assumed that in adults the virus has been
challenging the immune system for a long time, leading to a
major role of the immune response in the observed damage. In
line with this, we previously described the phenomenon of
immune tolerance when we evaluated the evolution of HCV
hypervariable region 1 (HVR1) in immunocompetent children
born to HCV-infected mothers [58]. The lack of HVR1
variability observed in the studied paediatric cases may reflect
the adaptation of the virus to a particularly tolerant immune
environment. Moreover, in a longer follow-up study including
those same paediatric patients, we observed in one case at
month 115 a switch of quasi species community after
60 months of an almost completely invariable HVR1 amino
acid sequence. Furthermore, the quasis peciess witch corre-
lated with the abrupt worsening of the patient’s clinical status
[59]. Based on these results we performed the pathogenesis
analysis on liver biopsy samples of this particular case during
the follow-up period. The present analysis revealed a decrease
in the infected hepatocyte number concomitant with an
increase of apoptotic cells, CD4+, CD8+, Foxp3+ and total
P-P/I lymphocyte number (Fig. S2). This last scenario observed
in a grown-up paediatric patient mirrors the one in adults.
Of course, differences between age groups such as patient’s
ages, infection acquisition age, duration of infection, immune
system characteristics according to age, sex and other
cofactors cannot be omitted when analysing the obtained
results. We are aware that it is the major limitation of our
study but, due to the incidence of CHC and the type of sample
evaluated here, standardization of these variables is almost
impossible, particularly in children. Even though the number of
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paediatric cases with severe liver damage may seem low, the
slow progression of liver injury renders this stage quite
uncommon in children.
Finally, this report represents a novel study that evaluates
intrahepatic infection, apoptosis and infiltrating lymphocytes in
liver samples to finally characterize their involvement in CHC
pathogenesis; these are aspects that, to the best of our
knowledge, have never before been thoroughly evaluated in
children. Although this study could be considered as a
single-centre descriptive analysis, it may lay down the ground-
work and lead to a larger multicentre cohort study that could
finally validate these findings.
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Figure S1. Schematic pathogenesis mechanism proposed:
HCV, apoptosis and immune response proved to be involved
in CHC pathogenesis of both paediatric and adult patients;
however, certain differences regarding the role that each
component plays in the final scenario were observed between
children and adults. In paediatric patients, it would be largely
HCV that participates in liver damage. HCV would not have a
direct effect on histological parameters, but instead it would
participate through apoptosis induction, which in turn con-
tributes to fibrosis development. In contrast, in adults
pathogenesis would be mainly associated with an exacerbated
immune response; furthermore, apoptosis could be a conse-
quence of the immune response to HCV.
Figure S2. Evaluation of one CHC paediatric case during
follow-up. Immunohistochemical detection of NS3+ and
casp-3a+ hepatocytes as well as CD4+, CD8+, Foxp3+,
CD20+ and total P-P/I lymphocytes in liver biopsies. Patient
(male, maternal HCV infection risk factor) who showed a rapid
progression of injury, requiring multiple biopsies during the
follow-up and resulting in severe hepatitis and incomplete
cirrhosis. Quantification: Labelled hepatocytes/total hepato-
cytes in 20 high-power fields (10009) for NS3 and casp-3a
immunostaining; (Labelled P-P/I lymphocytes)/(total P-P/I lym-
phocytes) in 10 portal tracts (4009) for CD4, CD8, Foxp3 and
CD20 immunostaining. Age at biopsy and histological features
of liver samples are shown under the graph. Fibrosis according
to METAVIR.
Tabla S1. Clinical, virological and histological features of
each HCV paediatric patient.
Table S2. Clinical, virological and histological features of
each HCV adult patient.
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